2:27 am AstraZeneca receives FDA approval for Bydureon Pen for once-weekly treatment of adults with Type 2 Diabetes – HedgeChatter

2:27 am AstraZeneca receives FDA approval for Bydureon Pen for once-weekly treatment of adults with Type 2 Diabetes

03 Mar

2:27 am AstraZeneca receives FDA approval for Bydureon Pen for once-weekly treatment of adults with Type 2 Diabetes

Bystocknews AZN, stock Comments Off

View todays social media effects on AZN

View the latest stocks trending across Twitter. Click to view dashboard

See who Astrazeneca is hiring next, click here to view

Author